Abbott India Ltd. (ABBOTINDIA): Abbott India Share Price Rises 2.32% to Rs 26,179
- September 15, 2026
- Posted by: Harsh Piplani
- Category: News
Abbott India Share Price rose today as the stock traded at Rs 26,179, up 2.32% from the previous close, with market capitalisation at Rs 54,368.68 crore. The latest Univest figures show a clear share price gain, but the data confirms the move rather than a company-specific catalyst. In Abbott India Stock News terms, the event matters because it combines a strong one-day price rise with a premium valuation, high profitability ratios and a large healthcare franchise. That mix is drawing attention in Stock Market Today screens and in broader Indian Stock Market searches for rising today names. Investors tracking Abbott India Share Price Today should watch whether the move is backed by fresh company updates, sector sentiment or follow-through in turnover. For now, the verified data explains what happened; it does not establish why.
Abbott India Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 26,179 |
| Previous Close | Rs 25,586.1 |
| Today's Move | Rs 592.9 (+2.32%) |
| Open | Rs 25,613.7 |
| High | Rs 26,235 |
| Low | Rs 25,586 |
| Turnover | Rs 3.77 crore |
| Market Capitalisation | Rs 54,368.68 crore |
| Market Cap Category | Large Cap |
Abbott India Ltd. (ABBOTINDIA) rose to Rs 26,179 from the previous close of Rs 25,586.1, a move of Rs 592.9 or 2.32%. The stock opened at Rs 25,613.7, reached a high of Rs 26,235, recorded a low of Rs 25,586.
Abbott India Share Price Today was marked by a steady intraday rise from Rs 25,613.7 at the open to Rs 26,235 at the high, while the low matched the previous close at Rs 25,586. The stock last traded at Rs 26,179, a gain of Rs 592.9 or 2.32% over the previous close. Turnover stood at Rs 3.77 crore, which shows the day’s market activity without changing the basic read on price action. In Abbott India Stock News, that makes the move notable as a price rise rather than a sharp gap event. The stock also sits comfortably above the previous close, so the market has so far accepted the higher price level. For readers searching Abbott India Share Price Live, the event is best understood as a same-day advance that is visible in price action, not in an identified catalyst.
Abbott India Ltd. (ABBOTINDIA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 54,368.68 crore |
| P/E Ratio | 33.67x |
| P/B Ratio | 10.5x |
| ROE | 34.67% |
| ROCE | 46.72% |
| EPS | Rs 759.87 |
| Book Value Per Share | Rs 2,435.93 |
| Dividend Yield | 2.56% |
Abbott India Ltd. (ABBOTINDIA) fundamental metrics show P/E 33.67x, P/B 10.5x, ROE 34.67%, ROCE 46.72%. These figures provide context only and are not a buy or sell signal.
Abbott India Ltd. has a market capitalisation of Rs 54368.68 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 33.67x, P/B at 10.5x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 34.67% and ROCE of 46.72%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 759.87, book value per share of Rs 2435.93, dividend yield of 2.56%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.72x, median ROE of 11.69%, median ROCE of 13.24%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 33.67x |
| Benchmark Median P/E | 32.72x |
| Benchmark Average P/E | 49.15x |
| Benchmark P/E Range | 3.34x to 693.7x |
| Company P/B Ratio | 10.5x |
| Benchmark Median P/B | 3.05x |
| Company ROE | 34.67% |
| Benchmark Median ROE | 11.69% |
| Company ROCE | 46.72% |
| Benchmark Median ROCE | 13.24% |
| Company Market Capitalisation | Rs 54,368.68 crore |
| Benchmark Median Market Cap | Rs 704.59 crore |
Abbott India Ltd. (ABBOTINDIA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Abbott India Ltd. (ABBOTINDIA) has a P/E ratio of 33.67x, which is above the benchmark median of 32.72x, a difference of +2.9%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Abbott India Ltd. (ABBOTINDIA) has a ROE of 34.67%, which is above the benchmark median of 11.69%, a difference of +196.58%. Abbott India Ltd. (ABBOTINDIA) has a ROCE of 46.72%, which is above the benchmark median of 13.24%, a difference of +252.87%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,41,957.5 | 36.54 | 5.11 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,47,576 | 84.64 | 14.02 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,233.01 | 86.76 | 21.08 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,670.55 | 24.74 | 4.14 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,272.68 | 32.72 | 3.14 | 11.83 | 16 |
Abbott India Ltd. (ABBOTINDIA) has a P/E ratio of 33.67x compared with the displayed peer median of 36.54x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 34.67% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 46.72% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Abbott India Ltd. (ABBOTINDIA) has a market capitalisation of Rs 54,368.68 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Abbott India
- Abbott India Share Price rose 2.32% today, making it a visible top gainer in healthcare screens.
- The stock traded between Rs 25,586 and Rs 26,235, giving a clear price action range for the day.
- Abbott India Share Price Today is backed by strong ROE of 34.67% and ROCE of 46.72%.
- The P/E of 33.67 and P/B of 10.5 keep valuation in focus for Abbott India Stock News readers.
- The Healthcare sector and Pharmaceuticals & Drugs industry provide the broader context for the move.
About Abbott India
Abbott India is part of the global Abbott healthcare group and operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company’s business is linked to medicines and healthcare products sold in India, making it a familiar name in Indian Stock Market healthcare coverage. For investors tracking Abbott India Company News, the stock’s interest usually comes from a mix of business stability, premium margins, strong profitability and brand strength in healthcare distribution. Abbott India Share Price also reflects the market’s willingness to assign a higher multiple to established consumer-facing healthcare franchises. While the day’s move is a same-day price rise rather than a confirmed event-led rally, the company’s operating profile helps explain why Abbott India Stock Performance stays on watchlists. Univest readers often follow such names because the combination of market capitalisation, returns and valuation can matter as much as the daily move itself.
Frequently Asked Questions
Why did Abbott India Share Price rise today?
Ans. Abbott India Share Price rose 2.32% to Rs 26,179, but the latest Univest data confirms the move rather than a company-specific catalyst. The stock traded above the previous close through the day.
What is Abbott India Share Price Today?
Ans. Abbott India Share Price Today is Rs 26,179. The stock added Rs 592.9 from the previous close of Rs 25,586.1, showing a clear same-day price rise on the latest market update.
How much did Abbott India stock gain in the market?
Ans. Abbott India gained Rs 592.9, which works out to 2.32%. The move lifted Abbott India Share Price to Rs 26,179 and kept it among the notable healthcare movers in today’s market.
What is Abbott India’s market capitalisation?
Ans. Abbott India’s market capitalisation is Rs 54,368.68 crore. Market cap shows company size, not quality, but it helps place Abbott India Share Price within the larger healthcare universe.
What do Abbott India’s P/E and P/B ratios show?
Ans. Abbott India has a P/E of 33.67 and a P/B of 10.5. Both ratios suggest a premium valuation, especially when compared with many pharma peers in the same industry.
How strong are Abbott India’s profitability ratios?
Ans. Abbott India reports ROE of 34.67% and ROCE of 46.72%, both strong numbers. These returns help explain why Abbott India Share Price stays relevant in fundamental analysis discussions.
What are Abbott India’s EPS and book value?
Ans. Abbott India’s EPS is Rs 759.87 and book value is Rs 2,435.93 per share. EPS reflects earnings per share, while book value shows the accounting net worth behind each share.
How does Abbott India compare with pharma peers?
Ans. Abbott India’s P/E of 33.67 is near Cipla and below Sun Pharma, while its ROE and ROCE are higher than the peers listed. That mix supports the premium seen in Abbott India Share Price.
Track Abbott India Share Price on Univest
Use Abbott India Ltd. (ABBOTINDIA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Abbott India Share Price on Univest for live share price updates, financial ratios, market cap context, 52-week levels, sector insights and Abbott India Stock Analysis. Univest helps readers follow Abbott India Share Price Today alongside broader Abbott India Stock News and Abbott India Latest News coverage. It is a practical way to keep an eye on price action, fundamentals and market context in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
